Recognizing Continuous and Discontinuous Adverse Drug Reaction Mentions from Social Media Using LSTM-CRF

Figure 1

Architecture of LSTM-CRF for continuous and discontinuous ADR mentions recognition. “” is the label for the th token defined in “BIOHD” or “Multilabel”.